ArticleCells2022

SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis.

Kangdi Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.